A Preliminary Study on Cancer Patients’ Quality of Life during the COVID-19 Pandemic

Ririn Afrian Sulistyawati, Santoso Santoso, Lalu Muhammad Panji Azali, Galih Setia Adi


Background: Cancer patients are 3.5 times more susceptible to COVID-19 than patients without cancer. The increasing number of COVID-19 patients is likely to impact cancer patients’ quality of life (QoL) significantly. This study aims to analyze the QoL of cancer patients during the COVID-19 pandemic.

Methods: The method used is quantitative with a cross-sectional research design. In this study, 60 respondents were selected using the Consecutive Sampling Technique. The patient’s QoL was measured once by utilizing The World Health Organization Quality of Life Brief Version (WHOQOL BREF) instrument. The QoL of cancer patients was shown in mean and standard deviation, and the correlation between respondent characteristics and QoL was analyzed with Spearman.

Results: The results showed that the average QoL of the respondents in the physical health was 30.36 ± 7.72, the intermediate psychological was 25.88 ± 9.14, the average social relationship was 59.90 ± 13.04, and the mean environment was 56.7 ± 10.93.

Conclusions: Respondents’ low QoL during the COVID-19 pandemic for all domains. This study implies the importance of paying attention to every domain of the QoL of cancer patients, especially during the COVID-19 pandemic.


cancer, COVID-19, quality of life

Full Text: View | Download

DOI: 10.33371/ijoc.v17i1.938

Article Metrics

Abstract View: 182,
PDF Download: 148


Ferguson N, Laydon D, Nedjati Gilani G, et al. Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. Imp Coll COVID-19 Response Team. 2020:1–20.

Wang C, Horby PW, Hayden F, Gao GF. A novel coronavirus outbreak of global health concern. Ann Oncol. 2020;7:19–21.

Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.

Center of Disease Control and Prevention (CDC). Coronavirus Disease 2019 (COVID-19) 2020 [Internet]. [cited 2020 March 26]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/specific-groups/high-risk-complications.html

Kamboj M, Sepkowitz KA. Nosocomial infections in patients with cancer. Lancet Oncol. 2009;10:589–97.

Longbottom ER, Torrance H, Owen HC, et al. Features of post-operative immune suppression are reversible with interferon gamma and independent of IL-6 pathways. Ann Surg. 2016;264:370–7.

Sica A, Massarotti M. Myeloid suppressor cells in cancer and autoimmunity. J Autoimmun 2017;85:117–25.

Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21:335–7.

Hewitt M, Rowland JH, Yancik R. Cancer survivors in the United States: age, health, and disability. J Gerontol A Biol Sci Med Sci. 2003;58:82–91.

Cella DF, Tulsky DS. Quality of life in cancer: Definition, purpose, and method of measurement. Cancer Invest. 1993;11:327–36.

WHO. WHOQOL: Measuring Quality of Life 2020 [Internet]. [cited 2020 April 6]. Available from: https://www.who.int/healthinfo/survey/whoqol-qualityoflife/en/

The WHOQOL Group. WHO Quality of Life Scale (WHOQOL). Psychol Med. 1998;28:551–8.

Bulamu NB, Kaambwa B, Ratcliffe J. A systematic review of instruments for measuring outcomes in economic evaluation within aged care. Health Qual Life Outcomes. 2015;13:1–23.

Malibary H, Zagzoog M, Banjari MA, et al. Quality of Life (QoL) among medical students in Saudi Arabia: A study using the WHOQOL-BREF instrument. BMC Med Educ. 2019;19:1–6.

Al-Quteimat OM, Amer AM. The Impact of the COVID-19 Pandemic on Cancer Patients. Am J Clin Oncol. 2020;00:1–4.

Lauby-Secretan B, Scoccianti C, Loomis D, et al. Body Fatness and Cancer — Viewpoint of the IARC Working Group. N Engl J Med. 2016;375:794–8.

Kitsis R, Riquelme J, Lavandero S. Heart disease and cancer – are the two killers colluding? Circulation. 2018;138:692–5.

American Cancer Society. American Cancer Society. Cancer Facts & Figures 2021. Atlanta: American Cancer Society; 2021 2021:1–72.

Holmes EA, O’Connor RC, Perry VH, et al. Mental illness during COVID-19. The Lancet Psychiatry. 2020;7:547–60.

Galea S, Merchant R, Lurie N. The Mental Health Consequences of COVID-19 and Physical Distancing The Need for Prevention and Early Intervention Opinion. JAMA Intern Med. 2020;180:817–8.

Barnett M, McDonnell G, DeRosa A, et al. Psychosocial outcomes and interventions among cancer survivors diagnosed during adolescence and young adulthood (AYA): a systematic review. J Cancer Surviv. 2016;10(5):814-31.

Kosir U, Wiedemann M, Wild J, Bowes L. Psychiatric disorders in adolescent cancer survivors: A systematic review of prevalence and predictors. Cancer Rep. 2019;2:1–15.

Brooks SK, Webster RK, Smith LE, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020;395:912–20.

Košir U, Loades M, Wild J, et al. The impact of COVID-19 on the cancer care of adolescents and young adults and their well-being: Results from an online survey conducted in the early stages of the pandemic. Cancer. 2020;126:4414–22.

Ciążyńska M, Pabianek M, Szczepaniak K, et al. Quality of life of cancer patients during coronavirus disease (COVID-19) pandemic. Psychooncology. 2020;29:1377–9.

Chen P, Mao L, Nassis GP, et al. Coronavirus disease (COVID-19): The need to maintain regular physical activity while taking precautions. J Sport Heal Sci 2020;9:103–4.

Alexander A, Fung S, Eichler M, et al. Quality of Life in Patients with Pancreatic Cancer before and during the COVID-19 Pandemic. Int J Environ Res Public Health. 2022;19:3731.


  • There are currently no refbacks.

Copyright (c) 2023 Indonesian Journal of Cancer

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.